Vassiliki A. Boussiotis
Impact in
- Immunology top 0.05%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune Response and Inflammation
- Oncology top 0.2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 125
- Immune Cell Function and Interaction 77
- T-cell and B-cell Immunology 52
- Immunotherapy and Immune Responses 32
- Immune cells in cancer 22
- Oncology 62
- Cancer Immunotherapy and Biomarkers 28
- CAR-T cell therapy research 23
- Co-authors
- Gordon J. Freeman (31 shared papers)Lee M. Nadler (27 shared papers)Nikolaos Patsoukis (42 shared papers)John G. Gribben (14 shared papers)Anthos Christofides (15 shared papers)Kankana Bardhan (12 shared papers)Laura Strauss (12 shared papers)Alla Berezovskaya (16 shared papers)
- Journals
- Blood (46 papers)The Journal of Immunology (12 papers)Proceedings of the National Academy of Sciences (7 papers)Biology of Blood and Marrow Transplantation (6 papers)Frontiers in Immunology (5 papers)
- Partner nations
- United StatesGreeceIsrael
In The Last Decade
Vassiliki A. Boussiotis
183 papers receiving 16.0k citations
Vassiliki A. Boussiotis's Hit Papers
Peers
Comparison fields: 5 of 136
- Immunology 9.1k
- Oncology 5.2k
- Immunology and Allergy 898
- Hematology 1.1k
- Genetics 922
Countries citing papers authored by Vassiliki A. Boussiotis
This map shows the geographic impact of Vassiliki A. Boussiotis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vassiliki A. Boussiotis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vassiliki A. Boussiotis more than expected).
Fields of papers citing papers by Vassiliki A. Boussiotis
This network shows the impact of papers produced by Vassiliki A. Boussiotis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vassiliki A. Boussiotis. The network helps show where Vassiliki A. Boussiotis may publish in the future.
Co-authors
The 25 scholars most cited alongside Vassiliki A. Boussiotis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 185 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway Hit paper breakdown → | 2016 | 1055 |
| 2 | PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation Hit paper breakdown → | 2015 | 930 |
| 3 | Cloning of B7-2: a CTLA-4 Counter-Receptor That Costimulates Human T Cell Proliferation Hit paper breakdown → | 1993 | 774 |
| 4 | The complex role of tumor-infiltrating macrophages Hit paper breakdown → | 2022 | 595 |
| 5 | B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4 Hit paper breakdown → | 1995 | 505 |
| 6 | The role of peroxisome proliferator-activated receptors (PPAR) in immune responses Hit paper breakdown → | 2020 | 490 |
| 7 | The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation Hit paper breakdown → | 2016 | 453 |
| 8 | 2012 | 448 | |
| 9 | 1997 | 373 | |
| 10 | 2000 | 356 | |
| 11 | Revisiting the PD-1 pathway Hit paper breakdown → | 2020 | 353 |
| 12 | 2006 | 349 | |
| 13 | 1999 | 346 | |
| 14 | 2000 | 340 | |
| 15 | 2001 | 336 | |
| 16 | Targeted deletion of PD-1 in myeloid cells induces antitumor immunity Hit paper breakdown → | 2020 | 322 |
| 17 | 1995 | 289 | |
| 18 | 1994 | 282 | |
| 19 | 2004 | 260 | |
| 20 | 2003 | 234 |
About Vassiliki A. Boussiotis
Vassiliki A. Boussiotis is a scholar working on Immunology, Oncology, Molecular Biology, Hematology and Genetics, having authored 185 papers that have together received 16.2k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (77 papers), T-cell and B-cell Immunology (52 papers), Immunotherapy and Immune Responses (32 papers), Cancer Immunotherapy and Biomarkers (28 papers), CAR-T cell therapy research (23 papers), Immune cells in cancer (22 papers), Hematopoietic Stem Cell Transplantation (20 papers) and Chronic Lymphocytic Leukemia Research (18 papers). The work is most often cited by research in Immunology (9.1k citations), Oncology (5.2k citations), Immunology and Allergy (898 citations), Hematology (1.1k citations) and Genetics (922 citations). Vassiliki A. Boussiotis has collaborated with scholars based in United States, Greece and Israel. Frequent co-authors include Gordon J. Freeman, Lee M. Nadler, Nikolaos Patsoukis, John G. Gribben, Anthos Christofides, Kankana Bardhan, Laura Strauss, Alla Berezovskaya, L M Nadler and Lequn Li. Their work appears in journals such as Blood, The Journal of Immunology, Proceedings of the National Academy of Sciences, Biology of Blood and Marrow Transplantation and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.